Global addressable patient population for CAR T-cell therapies 2019
In the next 5 to 10 years, the number of addressable patients worldwide for CAR-T cell therapies is expected to reach at least two million patients. In comparison, the global addressable patient population is currently (as of 2019) at some 450 thousand patients. This statistic depicts the estimated addressable patient population for CAR T-cell therapies worldwide in the next ten years, as of 2019.